{
  "run_id": "RUN_20260204_132700_1fed028ce5fb",
  "timestamp": "2026-02-04T16:26:08.752824",
  "document": "06_41927_2025_Article_585.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/PAPERS/06_41927_2025_Article_585.pdf",
  "pipeline_version": "0.8",
  "total_candidates": 44,
  "total_validated": 44,
  "total_rejected": 0,
  "total_ambiguous": 0,
  "diseases": [
    {
      "matched_text": "ANCA-Associated vasculitis",
      "preferred_label": "Anti-neutrophil cytoplasmic antibody-associated vasculitis",
      "abbreviation": "AAV",
      "confidence": 1.0,
      "is_rare_disease": true,
      "category": "immunology",
      "codes": {
        "icd10": null,
        "icd11": "4A44.AZ",
        "snomed": "722191003",
        "mondo": null,
        "orpha": "ORPHA:156152",
        "umls": null,
        "mesh": "D056648"
      },
      "all_identifiers": [
        {
          "system": "ORPHA",
          "code": "ORPHA:156152",
          "display": null
        },
        {
          "system": "ICD-11",
          "code": "4A44.AZ",
          "display": null
        },
        {
          "system": "SNOMED-CT",
          "code": "722191003",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D056648",
          "display": null
        }
      ],
      "context": "Schirmer JH, Wright MN, Herrmann K, Laudien M, Nélle B, Reinhold-Keller E, et al. Myeloperoxidase-Antineutrophil cytoplasmic antibody (ANCA)-Positive granulomatosis with polyangiitis (Wegener's) is a clinically distinct subset of ANCA-Associated vasculitis: A retrospective analysis of 315 patients from a German vasculitis referral center. Arthritis Rheumatol. 2016;68(12):2953-63.",
      "page": 10,
      "mention_count": 2,
      "pages_mentioned": [
        1,
        10
      ],
      "lexicon_source": "disease_lexicon_anca.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "EGPA",
      "preferred_label": "Eosinophilic granulomatosis with polyangiitis",
      "abbreviation": "EGPA",
      "confidence": 0.97,
      "is_rare_disease": true,
      "category": "rare_disease",
      "codes": {
        "icd10": "M30.1",
        "icd11": "4A44.A1",
        "snomed": "82275008",
        "mondo": null,
        "orpha": "ORPHA:183",
        "umls": "C0008728",
        "mesh": "D015267"
      },
      "all_identifiers": [
        {
          "system": "ORPHA",
          "code": "ORPHA:183",
          "display": null
        },
        {
          "system": "ICD-10",
          "code": "M30.1",
          "display": null
        },
        {
          "system": "ICD-11",
          "code": "4A44.A1",
          "display": null
        },
        {
          "system": "SNOMED-CT",
          "code": "82275008",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "C0008728",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D015267",
          "display": null
        }
      ],
      "context": "Exclusion criteria’s: patients meet criteria for EGPA, patient has small vessels features, ANCA + but no GPA features, biopsy or imaging evidence consistent with PAN {12].",
      "page": 2,
      "mention_count": 2,
      "pages_mentioned": [
        2,
        8
      ],
      "lexicon_source": "disease_lexicon_anca.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Churg-Strauss Syndrome",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "central nervous system vasculitis",
      "preferred_label": "central nervous system vasculitis",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": "neurology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0003346",
        "orpha": null,
        "umls": "UMLS:C0751878",
        "mesh": "MESH:D020293"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0003346",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:525",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:148408",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D020293",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C84622",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0751878",
          "display": null
        }
      ],
      "context": "1. At diagnosis, the most common organ system involvements were otologic, nasal, sinus, ocular, pulmonary, subglottic, followed by eosinophilia, facial nerve palsy, dermatologic, central nervous system vasculitis, asthma, and renal involvement. Serologically, 29 patients were MPO-positive and 142 patients were PR3-positive (Fig. 2). Additionally, 52 patients presented with pseudotumor-like manifestations (Supplementary Fig. 1). Out of our 220 patients, 3 had eosinophilia above 10% and 2 had asthma, but all",
      "page": 4,
      "mention_count": 1,
      "pages_mentioned": [
        4
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Lupus Vasculitis Central Nervous System",
        "AIDS Arteritis Central Nervous System"
      ],
      "pubtator_normalized_name": "Vasculitis Central Nervous System",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "granulomatosis with polyangiitis",
      "preferred_label": "Granulomatosis with polyangiitis",
      "abbreviation": "GPA",
      "confidence": 1.0,
      "is_rare_disease": true,
      "category": "rare_disease",
      "codes": {
        "icd10": "M31.3",
        "icd11": "4A44.A2",
        "snomed": "195353004",
        "mondo": null,
        "orpha": "ORPHA:900",
        "umls": "C3495801",
        "mesh": "D014890"
      },
      "all_identifiers": [
        {
          "system": "ORPHA",
          "code": "ORPHA:900",
          "display": null
        },
        {
          "system": "ICD-10",
          "code": "M31.3",
          "display": null
        },
        {
          "system": "ICD-11",
          "code": "4A44.A2",
          "display": null
        },
        {
          "system": "SNOMED-CT",
          "code": "195353004",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "C3495801",
          "display": null
        },
        {
          "system": "UMLS_CUI_alt",
          "code": "C0018202",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D014890",
          "display": null
        }
      ],
      "context": "Gastrointestinal involvement in granulomatosis with polyangiitis: frequency, clinical impact, and prognostic implications in a retrospective cohort study",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "disease_lexicon_anca.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Churg-Strauss Syndrome"
      ],
      "pubtator_normalized_name": "Granulomatosis with Polyangiitis",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "ALT",
      "preferred_label": "Well-differentiated liposarcoma",
      "abbreviation": "ALT",
      "confidence": 0.95,
      "is_rare_disease": true,
      "category": "oncology",
      "codes": {
        "icd10": "C49.9",
        "icd11": null,
        "snomed": null,
        "mondo": null,
        "orpha": "ORPHA:99971",
        "umls": null,
        "mesh": "D008080"
      },
      "all_identifiers": [
        {
          "system": "ORPHA",
          "code": "ORPHA:99971",
          "display": null
        },
        {
          "system": "ICD-10",
          "code": "C49.9",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D008080",
          "display": "Liposarcoma"
        }
      ],
      "context": "agnosis, time from symptom onset to diagnosis, and follow-up duration. Clinical features: organ involvement and symptoms at presentation, assessed using the Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS-WG). Gastrointestinal symptoms, including elevated liver enzymes (AST, ALT >79 IU/L; ALP > 306 IU/L), GI bleeding, diarrhea, nausea, vomiting, mesenteric ischemia, ascites, pancreatitis, hepatomegaly, hepatitis, and abdominal pain, will be documented. Treatment regimens: types, doses, and duration of induction therapies (cyclophosphamide,",
      "page": 3,
      "mention_count": 1,
      "pages_mentioned": [
        3
      ],
      "lexicon_source": "2025_08_rare_disease_acronyms.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Liposarcoma",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "EMA",
      "preferred_label": "Epilepsy with eyelid myoclonia",
      "abbreviation": "EMA",
      "confidence": 0.95,
      "is_rare_disease": true,
      "category": "neurology",
      "codes": {
        "icd10": "G40.3",
        "icd11": "8A61.2Y",
        "snomed": null,
        "mondo": null,
        "orpha": "ORPHA:139431",
        "umls": null,
        "mesh": "D004614"
      },
      "all_identifiers": [
        {
          "system": "ORPHA",
          "code": "ORPHA:139431",
          "display": null
        },
        {
          "system": "ICD-10",
          "code": "G40.3",
          "display": null
        },
        {
          "system": "ICD-11",
          "code": "8A61.2Y",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D004614",
          "display": "Emaciation"
        }
      ],
      "context": "This is a retrospective cohort study involving Iranian patients diagnosed with GPA according to the 1990 American College of Rheumatology (ACR) criteria and the European Medicines Agency (EMA) algorithm. The study includes all patients aged 16 years or older who were either hospitalized or seen in the rheumatology outpatient clinic at Amir Alam Hospital between 2013 and 2021. Based on hospital records and clinical estimates, approximately 30-40 GPA new cases are seen annually with stron",
      "page": 2,
      "mention_count": 1,
      "pages_mentioned": [
        2
      ],
      "lexicon_source": "2025_08_rare_disease_acronyms.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Emanuel syndrome"
      ],
      "pubtator_normalized_name": "Emaciation",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "Med",
      "preferred_label": "Multiple epiphyseal dysplasia",
      "abbreviation": "MED",
      "confidence": 0.95,
      "is_rare_disease": true,
      "category": "rare_disease",
      "codes": {
        "icd10": null,
        "icd11": "LD24.61",
        "snomed": null,
        "mondo": null,
        "orpha": "ORPHA:251",
        "umls": null,
        "mesh": "C535501"
      },
      "all_identifiers": [
        {
          "system": "ORPHA",
          "code": "ORPHA:251",
          "display": null
        },
        {
          "system": "ICD-11",
          "code": "LD24.61",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "C535501",
          "display": "Epiphyseal dysplasia multiple 1"
        }
      ],
      "context": "2. Potentas-Policewicz M, Fijolek J. Granulomatosis with polyangiitis: clinical characteristics and updates in diagnosis. Front Med. 2024;11.",
      "page": 10,
      "mention_count": 1,
      "pages_mentioned": [
        10
      ],
      "lexicon_source": "2025_08_rare_disease_acronyms.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Epiphyseal dysplasia multiple 4",
        "Epiphyseal dysplasia multiple 3",
        "Osteochondrodysplasias"
      ],
      "pubtator_normalized_name": "Epiphyseal dysplasia multiple 1",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "MHF",
      "preferred_label": "Marburg hemorrhagic fever",
      "abbreviation": "MHF",
      "confidence": 0.95,
      "is_rare_disease": true,
      "category": "rare_disease",
      "codes": {
        "icd10": "A98.3",
        "icd11": "1D60.1",
        "snomed": null,
        "mondo": null,
        "orpha": "ORPHA:99826",
        "umls": null,
        "mesh": "D008379"
      },
      "all_identifiers": [
        {
          "system": "ORPHA",
          "code": "ORPHA:99826",
          "display": null
        },
        {
          "system": "ICD-10",
          "code": "A98.3",
          "display": null
        },
        {
          "system": "ICD-11",
          "code": "1D60.1",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D008379",
          "display": "Marburg Virus Disease"
        }
      ],
      "context": "GS and AR designed the study. MHF and AR wrote the manuscript. SFA and MS and AR did the analysis and designed the graphs. MM supervised the study. All authors have read and confirmed the manuscript.",
      "page": 9,
      "mention_count": 1,
      "pages_mentioned": [
        9
      ],
      "lexicon_source": "2025_08_rare_disease_acronyms.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Marburg Virus Disease",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "MPA",
      "preferred_label": "Microscopic polyangiitis",
      "abbreviation": "MPA",
      "confidence": 0.95,
      "is_rare_disease": true,
      "category": "rare_disease",
      "codes": {
        "icd10": "M31.7",
        "icd11": "4A44.A0",
        "snomed": null,
        "mondo": null,
        "orpha": "ORPHA:727",
        "umls": null,
        "mesh": "D055953"
      },
      "all_identifiers": [
        {
          "system": "ORPHA",
          "code": "ORPHA:727",
          "display": null
        },
        {
          "system": "ICD-10",
          "code": "M31.7",
          "display": null
        },
        {
          "system": "ICD-11",
          "code": "4A44.A0",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D055953",
          "display": "Microscopic Polyangiitis"
        }
      ],
      "context": "Based on EMA and CHCC 2012 the patient in four ways diagnosed GPA (Fig. 1): (1) Based on ACR 1990 diagnosed GPA, (2) Biopsy proven tissue sample for GPA, (3) Tissue sample confirmed MPA but clinical sign and symptoms of GPA, (4) ANCA positive and clinical features of GPA without tissue sample.",
      "page": 2,
      "mention_count": 1,
      "pages_mentioned": [
        2
      ],
      "lexicon_source": "2025_08_rare_disease_acronyms.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Microscopic Polyangiitis",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "microscopic polyangiitis",
      "preferred_label": "microscopic polyangiitis",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": "ICD10CM:M31.7",
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0019124",
        "orpha": "Orphanet:727",
        "umls": "UMLS:C2347126",
        "mesh": "MESH:D055953"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0019124",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:1000784",
          "display": null
        },
        {
          "system": "GARD",
          "code": "GARD:3652",
          "display": null
        },
        {
          "system": "ICD-10-CM",
          "code": "ICD10CM:M31.7",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:389393",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D055953",
          "display": null
        },
        {
          "system": "MedDRA",
          "code": "MedDRA:10063344",
          "display": null
        },
        {
          "system": "NANDO",
          "code": "NANDO:2200426",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C70549",
          "display": null
        },
        {
          "system": "Orphanet",
          "code": "Orphanet:727",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:239928004",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C2347126",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:999231798",
          "display": null
        }
      ],
      "context": "The prognostic significance of GI involvement in systemic vasculitis is not a novel finding; it has been a cornerstone of risk stratification for decades, most notably through its inclusion in the Five-Factor Score (FFS). Initially developed for polyarteritis nodosa (PAN), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA, then CSS), the FFS was revised and validated by the French Vasculi-tis Study Group (FVSG) in 2009 to include GPA. In this large cohort of 1,108 patients, the revised FFS identified four factors including age >65 years, cardiac involvem",
      "page": 8,
      "mention_count": 1,
      "pages_mentioned": [
        8
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Microscopic Polyangiitis",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "FFS",
      "preferred_label": "Femoral-facial syndrome",
      "abbreviation": "FFS",
      "confidence": 0.95,
      "is_rare_disease": true,
      "category": "rare_disease",
      "codes": {
        "icd10": "Q87.8",
        "icd11": "LD2F.1Y",
        "snomed": null,
        "mondo": null,
        "orpha": "ORPHA:1988",
        "umls": null,
        "mesh": "C537916"
      },
      "all_identifiers": [
        {
          "system": "ORPHA",
          "code": "ORPHA:1988",
          "display": null
        },
        {
          "system": "ICD-10",
          "code": "Q87.8",
          "display": null
        },
        {
          "system": "ICD-11",
          "code": "LD2F.1Y",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "C537916",
          "display": "Femoral facial syndrome"
        }
      ],
      "context": "The prognostic significance of GI involvement in systemic vasculitis is not a novel finding; it has been a cornerstone of risk stratification for decades, most notably through its inclusion in the Five-Factor Score (FFS). Initially developed for polyarteritis nodosa (PAN), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA, then CSS), the FFS was revised and validated by the French Vasculi-tis Study Group (FVSG) in 2009 to include GPA. In this large cohort of 1,108 patients, th",
      "page": 8,
      "mention_count": 1,
      "pages_mentioned": [
        8
      ],
      "lexicon_source": "2025_08_rare_disease_acronyms.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Femoral facial syndrome",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "intestinal perforation",
      "preferred_label": "intestinal perforation",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": "gastroenterology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0006807",
        "orpha": null,
        "umls": "UMLS:C0021845",
        "mesh": "MESH:D007416"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0006807",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:2074",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:1000987",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:777.6",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:9525",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D007416",
          "display": null
        },
        {
          "system": "MedDRA",
          "code": "MedDRA:10022694",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C39611",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:56905009",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0021845",
          "display": null
        }
      ],
      "context": "PA commonly presents with involvement of the upper and lower respiratory tract and kidneys, gastrointestinal (GI) manifestations are considered uncommon, reported in only 5—10% of cases [5]. Nevertheless, when present, GI involvement can lead to severe compli-cations, including mesenteric ischemia, intestinal perforation, and massive gastrointestinal bleeding, which can be fatal. GI symptoms in GPA can affect the entire digestive tract and may arise either as a direct manifestation of vasculitis or as collateral effects of immunosuppressive therapies used in disease management [6].",
      "page": 2,
      "mention_count": 1,
      "pages_mentioned": [
        2
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Intestinal Perforation",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "autoimmune vasculitis",
      "preferred_label": "autoimmune vasculitis",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": "immunology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0030703",
        "orpha": null,
        "umls": "UMLS:C1328843",
        "mesh": null
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0030703",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:0040097",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:730236",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:427213005",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C1328843",
          "display": null
        }
      ],
      "context": "Granulomatosis with polyangiitis (GPA), formerly known as Wegener’s granulomatosis, is a rare but potentially life-threatening autoimmune vasculitis classified under antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) [1]. It mostly affects small to medium sized vessels and may result in multiorgan dysfunction and noticeable mortality if it is left untreated [2, 3]. While GPA is uncommon in the pediatric population, it is",
      "page": 2,
      "mention_count": 1,
      "pages_mentioned": [
        2
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": null,
      "enrichment_source": null
    },
    {
      "matched_text": "PAN",
      "preferred_label": "Polyarteritis nodosa",
      "abbreviation": "PAN",
      "confidence": 0.95,
      "is_rare_disease": true,
      "category": "rare_disease",
      "codes": {
        "icd10": "M30.0",
        "icd11": "4A44.4",
        "snomed": null,
        "mondo": null,
        "orpha": "ORPHA:767",
        "umls": null,
        "mesh": "D010488"
      },
      "all_identifiers": [
        {
          "system": "ORPHA",
          "code": "ORPHA:767",
          "display": null
        },
        {
          "system": "ICD-10",
          "code": "M30.0",
          "display": null
        },
        {
          "system": "ICD-11",
          "code": "4A44.4",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D010488",
          "display": "Polyarteritis Nodosa"
        }
      ],
      "context": "Exclusion criteria’s: patients meet criteria for EGPA, patient has small vessels features, ANCA + but no GPA features, biopsy or imaging evidence consistent with PAN {12].",
      "page": 2,
      "mention_count": 1,
      "pages_mentioned": [
        2
      ],
      "lexicon_source": "2025_08_rare_disease_acronyms.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Polyarteritis Nodosa",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "polyarteritis nodosa",
      "preferred_label": "polyarteritis nodosa",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": "ICD10CM:M30.0",
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0019170",
        "orpha": "Orphanet:767",
        "umls": "UMLS:C0031036",
        "mesh": "MESH:D010488"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0019170",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:9810",
          "display": null
        },
        {
          "system": "GARD",
          "code": "GARD:7360",
          "display": null
        },
        {
          "system": "ICD-10-CM",
          "code": "ICD10CM:M30.0",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:446.0",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:14681",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D010488",
          "display": null
        },
        {
          "system": "MedDRA",
          "code": "MedDRA:10036024",
          "display": null
        },
        {
          "system": "NANDO",
          "code": "NANDO:2200425",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C26847",
          "display": null
        },
        {
          "system": "NORD",
          "code": "NORD:1588",
          "display": null
        },
        {
          "system": "Orphanet",
          "code": "Orphanet:767",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:155441006",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0031036",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:1419332129",
          "display": null
        }
      ],
      "context": "The prognostic significance of GI involvement in systemic vasculitis is not a novel finding; it has been a cornerstone of risk stratification for decades, most notably through its inclusion in the Five-Factor Score (FFS). Initially developed for polyarteritis nodosa (PAN), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA, then CSS), the FFS was revised and validated by the French Vasculi-tis Study Group (FVSG) in 2009 to include GPA. In this large cohort of 1,108 patients, the revised FFS identified four factors including",
      "page": 8,
      "mention_count": 1,
      "pages_mentioned": [
        8
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Polyarteritis Nodosa",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "rheumatoid arthritis",
      "preferred_label": "rheumatoid arthritis",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": "immunology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0008383",
        "orpha": "Orphanet:284130",
        "umls": "UMLS:C0003873",
        "mesh": "MESH:D001172"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0008383",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:7148",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:0000685",
          "display": null
        },
        {
          "system": "HP",
          "code": "HP:0001370",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:714.0",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:2078",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D001172",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C2884",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "OMIM:180300",
          "display": null
        },
        {
          "system": "Orphanet",
          "code": "Orphanet:284130",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:69896004",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0003873",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:576319925",
          "display": null
        }
      ],
      "context": "3. Pagnoux C, Mahr A, Cohen P, Guillevin L. Presentation and outcome of Gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Med (Baltim). 2005;84(2):1 15-28.",
      "page": 10,
      "mention_count": 1,
      "pages_mentioned": [
        10
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Arthritis Juvenile",
        "Rheumatoid Arthritis Systemic Juvenile",
        "Felty Syndrome"
      ],
      "pubtator_normalized_name": "Arthritis Rheumatoid",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "systemic vasculitis",
      "preferred_label": "systemic vasculitis",
      "abbreviation": null,
      "confidence": 0.85,
      "is_rare_disease": false,
      "category": "immunology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0800113",
        "orpha": null,
        "umls": "UMLS:C1318520",
        "mesh": "D056647"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0800113",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:230813",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C70635",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C1318520",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D056647",
          "display": "Systemic Vasculitis"
        }
      ],
      "context": "The prognostic significance of GI involvement in systemic vasculitis is not a novel finding; it has been a cornerstone of risk stratification for decades, most notably through its inclusion in the Five-Factor Score (FFS). Initially developed for polyarteritis nodosa (PAN), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA, then",
      "page": 8,
      "mention_count": 1,
      "pages_mentioned": [
        8
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Lupus Vasculitis Central Nervous System"
      ],
      "pubtator_normalized_name": "Systemic Vasculitis",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "renal insufficiency",
      "preferred_label": "renal insufficiency",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": "nephrology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0001106",
        "orpha": null,
        "umls": "UMLS:C0035078",
        "mesh": "MESH:D051437"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0001106",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:1074",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:1002048",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:586",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:11177",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D051437",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C4376",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:42399005",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0035078",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:761526554",
          "display": null
        }
      ],
      "context": "), and eosinophilic granulomatosis with polyangiitis (EGPA, then CSS), the FFS was revised and validated by the French Vasculi-tis Study Group (FVSG) in 2009 to include GPA. In this large cohort of 1,108 patients, the revised FFS identified four factors including age >65 years, cardiac involvement, renal insufficiency (creatinine > 150 mol/L), and GI involvement that were each independently associated with a higher 5-year mortality and accorded + 1 point. Our data strongly support this long-standing observation, confirming that GI involvement is a marker of severe disease. Furthermore, the 2009 FFS demonstrated",
      "page": 8,
      "mention_count": 1,
      "pages_mentioned": [
        8
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Renal Insufficiency Chronic",
        "Acute Kidney Injury",
        "Lutz Richner Landolt syndrome"
      ],
      "pubtator_normalized_name": "Renal Insufficiency",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "facial nerve palsy",
      "preferred_label": "facial nerve palsy",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": "ICD10CM:G51.0",
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0005665",
        "orpha": "Orphanet:2810",
        "umls": "UMLS:C0376175",
        "mesh": "MESH:D020330"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0005665",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:12506",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:0007167",
          "display": null
        },
        {
          "system": "ICD-10-CM",
          "code": "ICD10CM:G51.0",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:351.0",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:87660",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D020330",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C26769",
          "display": null
        },
        {
          "system": "Orphanet",
          "code": "Orphanet:2810",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:193093009",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0376175",
          "display": null
        }
      ],
      "context": "1. At diagnosis, the most common organ system involvements were otologic, nasal, sinus, ocular, pulmonary, subglottic, followed by eosinophilia, facial nerve palsy, dermatologic, central nervous system vasculitis, asthma, and renal involvement. Serologically, 29 patients were MPO-positive and 142 patients were PR3-positive (Fig. 2). Additionally, 52 patients presented with pseudotumor-like manifestations (Supplementary Fig. 1). Out of our 220 patients, 3 had",
      "page": 4,
      "mention_count": 1,
      "pages_mentioned": [
        4
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": null,
      "enrichment_source": null
    },
    {
      "matched_text": "splenic infarction",
      "preferred_label": "splenic infarction",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": "ICD10CM:D73.5",
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0006978",
        "orpha": null,
        "umls": "UMLS:C0037998",
        "mesh": "MESH:D013159"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0006978",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:2533",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:1001190",
          "display": null
        },
        {
          "system": "ICD-10-CM",
          "code": "ICD10CM:D73.5",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:289.59",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:52468",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D013159",
          "display": null
        },
        {
          "system": "MedDRA",
          "code": "MedDRA:10041648",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:22996003",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0037998",
          "display": null
        }
      ],
      "context": "g the course of the disease, but it should be noted that the patient also had proteinuria and kidney problems. Two patients are also mentioned in Supple-mentary Fig. 2 as having splenomegaly, and in fact, these patients number 2 and 18 had hepatosplenomegaly from the beginning and the cause was not splenic infarction or hypodense nodules. Patient 18 initially presented with",
      "page": 5,
      "mention_count": 1,
      "pages_mentioned": [
        5
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Splenic Infarction",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "PDS",
      "preferred_label": "Pendred syndrome",
      "abbreviation": null,
      "confidence": 0.6,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0010134",
        "orpha": "Orphanet:705",
        "umls": "UMLS:C0271829",
        "mesh": "MESH:C536648"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0010134",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:0060744",
          "display": null
        },
        {
          "system": "GARD",
          "code": "GARD:4271",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:82890",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:C536648",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C121745",
          "display": null
        },
        {
          "system": "NORD",
          "code": "NORD:2030",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "OMIM:274600",
          "display": null
        },
        {
          "system": "Orphanet",
          "code": "Orphanet:705",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:70348004",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0271829",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:1156056623",
          "display": null
        }
      ],
      "context": "39 0 PR3 ENT, KL, Geye, HF, Li 40 2 PR3 ENT, Li 34 Cyc PD, RTX, Cyc D 13 Cyc+Pulse = PD5,Aza L 34 Cyc+Pulse = PD5,Aza D 26 Cyc+Pulse = PD7.5 D 19 Cyc + Pulse PDS50,Aza L 9 Cyc PD2.5 L 32 Cyc + Pulse PD, RTX, Cyc D 28 Cyc+Pulse = PD60 D 17 Cyc+Pulse — Celcept, PD60 L 6 MTX MTX, PD30 D 18 Aza+pulse = PDS L 15 Aza+pulse = RTX L 30 Cyc+Pulse = PD30 D 35 Cyc+Pulse = PD45,Cyc D 6 MTX PD60,Cyc D 19 Cyc + Pulse PD60,Aza L 37 Cyc+Pulse = PDS D 9 Aza RTX L",
      "page": 5,
      "mention_count": 1,
      "pages_mentioned": [
        5
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Pendred syndrome",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "HF",
      "preferred_label": "Hydrops fetalis",
      "abbreviation": "HF",
      "confidence": 0.95,
      "is_rare_disease": true,
      "category": "rare_disease",
      "codes": {
        "icd10": "P83.2",
        "icd11": "KA85.0",
        "snomed": null,
        "mondo": null,
        "orpha": "ORPHA:1041",
        "umls": null,
        "mesh": "D015160"
      },
      "all_identifiers": [
        {
          "system": "ORPHA",
          "code": "ORPHA:1041",
          "display": null
        },
        {
          "system": "ICD-10",
          "code": "P83.2",
          "display": null
        },
        {
          "system": "ICD-11",
          "code": "KA85.0",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D015160",
          "display": "Hydrops Fetalis"
        }
      ],
      "context": "Patientno. Age LagofDx(months) Serology Organ involvment at GPA diagnosis First BVAS InductionTx MaintenanceTx Prognosis 65 3-ENT, LK, PM 391-Li, ENT. 38 0 PR3 Li, ENT, LK, eye, HF 63 4 PR3 ENT, K;S, Li 62 3 PR3 Li, GENT, L 68 2 PR3 ENT, Li 51 0-Li, ENT, LK, eye, S 56 2 PR3 ENT, Keye, C,Li 54. 6 PR3 ENT, LK, Li 28 4 PR3 ENT, LK, Li 68 0 PR3 ENT, L.Li, JM 69 0 PR3 ENT, Li, MJ 58 2 PR3 ENT, K,C, eye, Li 51 0 PR3 ENT, K,C, eye, MLi 50 4-ENT, Li 52 3 PR3 ENT, LG, Li 39 0 PR3 ENT,",
      "page": 5,
      "mention_count": 1,
      "pages_mentioned": [
        5
      ],
      "lexicon_source": "2025_08_rare_disease_acronyms.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Hydrops Fetalis",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "elevated liver enzymes",
      "preferred_label": "HELLP syndrome",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": true,
      "category": "rare_disease",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": null,
        "orpha": "ORPHA:244242",
        "umls": null,
        "mesh": "D017359"
      },
      "all_identifiers": [
        {
          "system": "ORPHA",
          "code": "ORPHA:244242",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D017359",
          "display": "HELLP Syndrome"
        }
      ],
      "context": "Results Gl involvement was observed in 18 patients (8.2%). The most common manifestations included hepatitis, mesenteric ischemia, diarrhea, pancreatitis, and elevated liver enzymes. Patients with Gl involvement had significantly higher BVAS scores (mean 21 vs. 15.8, p=0.004), a markedly increased mortality risk (hazard ratio= 3.24, p< 0.001), and a shorter time to first relapse (mean 5.2 vs. 10.3 months, p=0.041) compared to those without Gl symptoms.",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphanet_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "HELLP Syndrome",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "heart failure",
      "preferred_label": "heart failure",
      "abbreviation": null,
      "confidence": 0.85,
      "is_rare_disease": false,
      "category": "cardiology",
      "codes": {
        "icd10": "ICD10CM:I50",
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0005252",
        "orpha": null,
        "umls": "UMLS:C0018801",
        "mesh": "MESH:D006333"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0005252",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:0003144",
          "display": null
        },
        {
          "system": "ICD-10-CM",
          "code": "ICD10CM:I50",
          "display": null
        },
        {
          "system": "ICD10WHO",
          "code": "ICD10WHO:I50",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:428.9",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:6749",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D006333",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C50577",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:84114007",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0018801",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:1458683894",
          "display": null
        }
      ],
      "context": "ENT: ear, nose and throat, L: lung, K: kidney, P: pancreas, C: nervous system, M: mucosa, J: joint, S: skin, Li: liver, HF: heart failure, Cyc: cyclophosphamide, Aza: azathioprine, Pulse: pulse methylprednisolone, RTX: rituximab, PD: prednisolone",
      "page": 5,
      "mention_count": 1,
      "pages_mentioned": [
        5
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Heart Failure Diastolic",
        "Heart Failure Systolic",
        "Lowry Maclean syndrome"
      ],
      "pubtator_normalized_name": "Heart Failure",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "pancreatitis",
      "preferred_label": "pancreatitis",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": "gastroenterology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0004982",
        "orpha": null,
        "umls": "UMLS:C0030305",
        "mesh": "MESH:D010195"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0004982",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:4989",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:0000278",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:14586",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D010195",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C3306",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:75694006",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0030305",
          "display": null
        }
      ],
      "context": "Results Gl involvement was observed in 18 patients (8.2%). The most common manifestations included hepatitis, mesenteric ischemia, diarrhea, pancreatitis, and elevated liver enzymes. Patients with Gl involvement had significantly higher BVAS scores (mean 21 vs. 15.8, p=0.004), a markedly increased mortality risk (hazard ratio= 3.24, p< 0.001), and a shorter time to first relapse (mean 5.2 vs. 10.3 months, p=0.041) compared to those without Gl sympto",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Pancreatitis Chronic",
        "Pancreatitis Acute Necrotizing",
        "Pancreatitis Graft"
      ],
      "pubtator_normalized_name": "Pancreatitis",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "eosinophilia",
      "preferred_label": "eosinophilia",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": "ICD10CM:D72.11",
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0015691",
        "orpha": "Orphanet:168956",
        "umls": "UMLS:C1540912",
        "mesh": "MESH:D017681"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0015691",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:999",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:1001467",
          "display": null
        },
        {
          "system": "GARD",
          "code": "GARD:2804",
          "display": null
        },
        {
          "system": "ICD-10-CM",
          "code": "ICD10CM:D72.11",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:288.3",
          "display": null
        },
        {
          "system": "ICDO",
          "code": "ICDO:9964/3",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:280990",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D017681",
          "display": null
        },
        {
          "system": "MedDRA",
          "code": "MedDRA:10048643",
          "display": null
        },
        {
          "system": "NANDO",
          "code": "NANDO:2200806",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C27038",
          "display": null
        },
        {
          "system": "Orphanet",
          "code": "Orphanet:168956",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:419455006",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C1540912",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:110429919",
          "display": null
        }
      ],
      "context": "1. At diagnosis, the most common organ system involvements were otologic, nasal, sinus, ocular, pulmonary, subglottic, followed by eosinophilia, facial nerve palsy, dermatologic, central nervous system vasculitis, asthma, and renal involvement. Serologically, 29 patients were MPO-positive and 142 patients were PR3-positive (Fig. 2). Additionally, 52 patients presented with pseudotumor-like manifestations (Supplementary Fig. 1). Out of our",
      "page": 4,
      "mention_count": 1,
      "pages_mentioned": [
        4
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Drug Hypersensitivity Syndrome",
        "Eosinophilia-Myalgia Syndrome",
        "Wells syndrome"
      ],
      "pubtator_normalized_name": "Eosinophilia",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "GI bleeding",
      "preferred_label": "GI bleeding",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0004242",
        "orpha": null,
        "umls": null,
        "mesh": "MESH:D010438"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0004242",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:749",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:578.9",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D010438",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:74474003",
          "display": null
        }
      ],
      "context": "t to diagnosis, and follow-up duration. Clinical features: organ involvement and symptoms at presentation, assessed using the Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS-WG). Gastrointestinal symptoms, including elevated liver enzymes (AST, ALT >79 IU/L; ALP > 306 IU/L), GI bleeding, diarrhea, nausea, vomiting, mesenteric ischemia, ascites, pancreatitis, hepatomegaly, hepatitis, and abdominal pain, will be documented. Treatment regimens: types, doses, and duration of induction therapies (cyclophosphamide,",
      "page": 3,
      "mention_count": 1,
      "pages_mentioned": [
        3
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": null,
      "enrichment_source": null
    },
    {
      "matched_text": "proteinuria",
      "preferred_label": "proteinuria",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": "ICD10CM:R80",
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0003634",
        "orpha": null,
        "umls": "UMLS:C0033687",
        "mesh": "MESH:D011507"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0003634",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:576",
          "display": null
        },
        {
          "system": "ICD-10-CM",
          "code": "ICD10CM:R80",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:791.0",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:10976",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D011507",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0033687",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:930895737",
          "display": null
        }
      ],
      "context": "2 is related to patient number 1, who initially pre-sented with pancreatic pseudotumor. The ascites symptom mentioned in Supplementary Fig. 2 is for patient number 4, who initially had hepatitis and developed ascites during the course of the disease, but it should be noted that the patient also had proteinuria and kidney problems. Two patients are also mentioned in Supple-mentary Fig. 2 as having splenomegaly, and in fact, these patients number 2 and 18 had hepatosplenomegaly from the beginning and the cause was not splenic infarction or hypodense nodules. Patient 18 initially presented with",
      "page": 5,
      "mention_count": 1,
      "pages_mentioned": [
        5
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Pre-Eclampsia",
        "Donnai-Barrow syndrome",
        "Low Molecular Weight Proteinuria with Hypercalciuria and Nephrocalcinosis"
      ],
      "pubtator_normalized_name": "Proteinuria",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "PM",
      "preferred_label": "Pyomyositis",
      "abbreviation": "PM",
      "confidence": 0.95,
      "is_rare_disease": true,
      "category": "rare_disease",
      "codes": {
        "icd10": "M60.0",
        "icd11": "FB30",
        "snomed": null,
        "mondo": null,
        "orpha": "ORPHA:764",
        "umls": null,
        "mesh": "D052880"
      },
      "all_identifiers": [
        {
          "system": "ORPHA",
          "code": "ORPHA:764",
          "display": null
        },
        {
          "system": "ICD-10",
          "code": "M60.0",
          "display": null
        },
        {
          "system": "ICD-11",
          "code": "FB30",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D052880",
          "display": "Pyomyositis"
        }
      ],
      "context": "Patientno. Age LagofDx(months) Serology Organ involvment at GPA diagnosis First BVAS InductionTx MaintenanceTx Prognosis 65 3-ENT, LK, PM 391-Li, ENT. 38 0 PR3 Li, ENT, LK, eye, HF 63 4 PR3 ENT, K;S, Li 62 3 PR3 Li, GENT, L 68 2 PR3 ENT, Li 51 0-Li, ENT, LK, eye, S 56 2 PR3 ENT, Keye, C,Li 54. 6 PR3 ENT, LK, Li 28 4 PR3 ENT, LK, Li 68 0 PR3 ENT, L.Li, JM 69 0 PR3 ENT, Li, MJ 58 2 PR3 ENT, K,C, eye, Li 51 0 PR3 ENT, K,C, eye, MLi 50 4",
      "page": 5,
      "mention_count": 1,
      "pages_mentioned": [
        5
      ],
      "lexicon_source": "2025_08_rare_disease_acronyms.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Pyomyositis",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "malignancy",
      "preferred_label": "malignancy",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0004992",
        "orpha": null,
        "umls": "UMLS:C0006826",
        "mesh": "D009369"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0004992",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:162",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:199.1",
          "display": null
        },
        {
          "system": "ICDO",
          "code": "ICDO:8000/3",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:14297",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C9305",
          "display": null
        },
        {
          "system": "ONCOTREE",
          "code": "ONCOTREE:MT",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:363346000",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0006826",
          "display": null
        },
        {
          "system": "birnlex",
          "code": "birnlex:406",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D009369",
          "display": "Neoplasms"
        }
      ],
      "context": "(n=23), infectious (1=15), malignancy (m=5), and gastrointestinal hemorrhage (1 = 2) (The patients mentioned suffered from gastrointestinal bleeding at the start of induction therapy and had no pre-existing gastrointesti-nal symptoms). Two patients had overlapping cardiovas-cular and infectious causes.",
      "page": 7,
      "mention_count": 2,
      "pages_mentioned": [
        1,
        7
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Hematologic Neoplasms",
        "Leukemia Lymphocytic Chronic B-Cell",
        "Neoplasms Second Primary"
      ],
      "pubtator_normalized_name": "Neoplasms",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "infectious",
      "preferred_label": "infectious",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": "ICD10CM:A00-B99",
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0005550",
        "orpha": null,
        "umls": "UMLS:C0009450",
        "mesh": "MESH:D003141"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0005550",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:0050117",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:0005741",
          "display": null
        },
        {
          "system": "ICD-10-CM",
          "code": "ICD10CM:A00-B99",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:136.9",
          "display": null
        },
        {
          "system": "IDO",
          "code": "IDO:0000436",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:1057",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D003141",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C26726",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:40733004",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0009450",
          "display": null
        }
      ],
      "context": "(n=23), infectious (1=15), malignancy (m=5), and gastrointestinal hemorrhage (1 = 2) (The patients mentioned suffered from gastrointestinal bleeding at the start of induction therapy and had no pre-existing gastrointesti-nal symptoms). Two patients had overlapping cardiovas-cular and infectious causes.",
      "page": 7,
      "mention_count": 2,
      "pages_mentioned": [
        7
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Infectious Mononucleosis",
        "Travel-Related Illness",
        "Noncommunicable Diseases"
      ],
      "pubtator_normalized_name": "Communicable Diseases",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "hepatitis",
      "preferred_label": "Hepatitis",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": "gastroenterology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0002251",
        "orpha": null,
        "umls": "UMLS:C0019158",
        "mesh": "MESH:D006505"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0002251",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:2237",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:571.41",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:5515",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D006505",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C3095",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:197268000",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0019158",
          "display": null
        }
      ],
      "context": "Results Gl involvement was observed in 18 patients (8.2%). The most common manifestations included hepatitis, mesenteric ischemia, diarrhea, pancreatitis, and elevated liver enzymes. Patients with Gl involvement had significantly higher BVAS scores (mean 21 vs. 15.8, p=0.004), a markedly increased mortality risk (hazard ratio= 3.24, p< 0.001), and a shorter time to first relapse (mean 5.2 vs. 10.3 months,",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Hepatitis C Chronic",
        "Hepatitis C",
        "Hepatitis E"
      ],
      "pubtator_normalized_name": "Hepatitis B",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "gastritis",
      "preferred_label": "gastritis",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0004966",
        "orpha": null,
        "umls": "UMLS:C0017152",
        "mesh": "MESH:D005756"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0004966",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:4029",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:0000217",
          "display": null
        },
        {
          "system": "HP",
          "code": "HP:0005263",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:535.41",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:4843",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D005756",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C26780",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:4556007",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0017152",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:1871672644",
          "display": null
        }
      ],
      "context": "Despite numerous recent case reports describing GPArelated GI complications such as elevated liver enzymes, hepatitis, esophageal ulcers, gastritis, and colitis, large-scale cohort studies examining the frequency of GI involvement and its impact on treatment response and prognosis remain limited [8, 9]. A better comprehension of these features could contribute to improved diagnostic accuracy, earlier therapeutic intervention, and potentially b",
      "page": 2,
      "mention_count": 1,
      "pages_mentioned": [
        2
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Gastritis Atrophic",
        "Gastritis Hypertrophic",
        "Eosinophilic enteropathy"
      ],
      "pubtator_normalized_name": "Gastritis",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "arthritis",
      "preferred_label": "arthritis",
      "abbreviation": null,
      "confidence": 0.85,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0005578",
        "orpha": null,
        "umls": "UMLS:C0003864",
        "mesh": "MESH:D001168"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0005578",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:848",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:0005856",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:2043",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D001168",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C2883",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:3723001",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0003864",
          "display": null
        },
        {
          "system": "Wikipedia",
          "code": "Wikipedia:Arthritis",
          "display": null
        }
      ],
      "context": "arthritis, 1,0%",
      "page": 4,
      "mention_count": 1,
      "pages_mentioned": [
        4
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Arthritis",
        "Arthritis Psoriatic",
        "Arthritis Infectious"
      ],
      "pubtator_normalized_name": "Arthritis Rheumatoid",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "scleritis",
      "preferred_label": "scleritis",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": "ICD10CM:H15.0",
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0001718",
        "orpha": null,
        "umls": "UMLS:C0036416",
        "mesh": "MESH:D015423"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0001718",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:13452",
          "display": null
        },
        {
          "system": "HP",
          "code": "HP:0100532",
          "display": null
        },
        {
          "system": "ICD-10-CM",
          "code": "ICD10CM:H15.0",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:379.00",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:48585",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D015423",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C119046",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:78370002",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0036416",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:2097802831",
          "display": null
        }
      ],
      "context": "21 Ahmed A, Foster CS. Cyclophosphamide or rituximab treatment of scleritis and uveitis for patients with granulomatosis with polyangiitis. Ophthalmic Res. 2019;61(1):44-50.",
      "page": 10,
      "mention_count": 1,
      "pages_mentioned": [
        10
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Scleritis",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "ischemia",
      "preferred_label": "ischemia",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0005053",
        "orpha": null,
        "umls": "UMLS:C0022116",
        "mesh": "MESH:D054058"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0005053",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:326",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:5899",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D054058",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C34738",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:52674009",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0022116",
          "display": null
        }
      ],
      "context": "Results Gl involvement was observed in 18 patients (8.2%). The most common manifestations included hepatitis, mesenteric ischemia, diarrhea, pancreatitis, and elevated liver enzymes. Patients with Gl involvement had significantly higher BVAS scores (mean 21 vs. 15.8, p=0.004), a markedly increased mortality risk (hazard ratio= 3.24, p< 0.001), and a shorter time to first relapse (mean 5.2 vs. 10.3 months, p=0.041) compared to",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Brain Ischemia",
        "Myocardial Ischemia",
        "Reperfusion Injury"
      ],
      "pubtator_normalized_name": "Ischemia",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "diarrhea",
      "preferred_label": "diarrhea",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0001673",
        "orpha": null,
        "umls": "UMLS:C1290807",
        "mesh": "MESH:D003967"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0001673",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:13250",
          "display": null
        },
        {
          "system": "HP",
          "code": "HP:0002014",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:009.2",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:713159",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D003967",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C2987",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:128333008",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C1290807",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:116759077",
          "display": null
        }
      ],
      "context": "Results Gl involvement was observed in 18 patients (8.2%). The most common manifestations included hepatitis, mesenteric ischemia, diarrhea, pancreatitis, and elevated liver enzymes. Patients with Gl involvement had significantly higher BVAS scores (mean 21 vs. 15.8, p=0.004), a markedly increased mortality risk (hazard ratio= 3.24, p< 0.001), and a shorter time to first relapse (mean 5.2 vs. 10.3 months, p=0.041) compared to those wit",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Diarrhea 5 With Tufting Enteropathy Congenital",
        "Diarrhea 3 Secretory Sodium Congenital",
        "Dysentery"
      ],
      "pubtator_normalized_name": "Diarrhea",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "colitis",
      "preferred_label": "colitis",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": "gastroenterology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0005292",
        "orpha": null,
        "umls": "UMLS:C0009319",
        "mesh": "MESH:D003092"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0005292",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:0060180",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:0003872",
          "display": null
        },
        {
          "system": "HP",
          "code": "HP:0002583",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:558.9",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:40385",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D003092",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C26723",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:64226004",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0009319",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:1870792958",
          "display": null
        }
      ],
      "context": "Despite numerous recent case reports describing GPArelated GI complications such as elevated liver enzymes, hepatitis, esophageal ulcers, gastritis, and colitis, large-scale cohort studies examining the frequency of GI involvement and its impact on treatment response and prognosis remain limited [8, 9]. A better comprehension of these features could contribute to improved diagnostic accuracy, earlier therapeutic intervention, and potentially better outcome",
      "page": 2,
      "mention_count": 1,
      "pages_mentioned": [
        2
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Colitis",
        "Crohn Disease",
        "Cytomegalovirus Infections"
      ],
      "pubtator_normalized_name": "Colitis Ulcerative",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "uveitis",
      "preferred_label": "uveitis",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0020283",
        "orpha": "Orphanet:98715",
        "umls": "UMLS:C0042164",
        "mesh": "MESH:D014605"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0020283",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:13141",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:1001231",
          "display": null
        },
        {
          "system": "GARD",
          "code": "GARD:19549",
          "display": null
        },
        {
          "system": "HP",
          "code": "HP:0000554",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:52961",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D014605",
          "display": null
        },
        {
          "system": "MedDRA",
          "code": "MedDRA:10046851",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C26909",
          "display": null
        },
        {
          "system": "Orphanet",
          "code": "Orphanet:98715",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:128473001",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0042164",
          "display": null
        }
      ],
      "context": "21 Ahmed A, Foster CS. Cyclophosphamide or rituximab treatment of scleritis and uveitis for patients with granulomatosis with polyangiitis. Ophthalmic Res. 2019;61(1):44-50.",
      "page": 10,
      "mention_count": 1,
      "pages_mentioned": [
        10
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Uveitis Anterior",
        "Uveitis Posterior",
        "Uveitis Intermediate"
      ],
      "pubtator_normalized_name": "Uveitis",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "ulcers",
      "preferred_label": "ulcers",
      "abbreviation": null,
      "confidence": 0.85,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0043839",
        "orpha": null,
        "umls": "UMLS:C0041582",
        "mesh": "MESH:D014456"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0043839",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:22541",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D014456",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C3426",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:429040005",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0041582",
          "display": null
        }
      ],
      "context": "4. Nasal or oral inflammation (e.g., ulcers, purulent or bloody discharge).",
      "page": 2,
      "mention_count": 1,
      "pages_mentioned": [
        2
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Pressure Ulcer",
        "Peptic Ulcer",
        "Carcinoma Basal Cell"
      ],
      "pubtator_normalized_name": "Ulcer",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "asthma",
      "preferred_label": "asthma",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": "pulmonology",
      "codes": {
        "icd10": "ICD10CM:J45",
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0004979",
        "orpha": null,
        "umls": "UMLS:C0004096",
        "mesh": "MESH:D001249"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0004979",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:2841",
          "display": null
        },
        {
          "system": "HP",
          "code": "HP:0002099",
          "display": null
        },
        {
          "system": "ICD-10-CM",
          "code": "ICD10CM:J45",
          "display": null
        },
        {
          "system": "ICD10WHO",
          "code": "ICD10WHO:J45",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:493.9",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:2109",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D001249",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C28397",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:31387002",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0004096",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:1656445230",
          "display": null
        }
      ],
      "context": "1. At diagnosis, the most common organ system involvements were otologic, nasal, sinus, ocular, pulmonary, subglottic, followed by eosinophilia, facial nerve palsy, dermatologic, central nervous system vasculitis, asthma, and renal involvement. Serologically, 29 patients were MPO-positive and 142 patients were PR3-positive (Fig. 2). Additionally, 52 patients presented with pseudotumor-like manifestations (Supplementary Fig. 1). Out of our 220 patients, 3 had eosinophilia above 10% and 2 had asthma, but all of these",
      "page": 4,
      "mention_count": 1,
      "pages_mentioned": [
        4
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Status Asthmaticus",
        "Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome",
        "Ige Responsiveness Atopic"
      ],
      "pubtator_normalized_name": "Asthma",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "GPA",
      "preferred_label": "GPA",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": "ICD10CM:M31.3",
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0012105",
        "orpha": "Orphanet:900",
        "umls": "UMLS:C3495801",
        "mesh": "MESH:D014890"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0012105",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:12132",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:0005297",
          "display": null
        },
        {
          "system": "GARD",
          "code": "GARD:7880",
          "display": null
        },
        {
          "system": "ICD-10-CM",
          "code": "ICD10CM:M31.3",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:446.4",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:811223",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D014890",
          "display": null
        },
        {
          "system": "MedDRA",
          "code": "MedDRA:10047888",
          "display": null
        },
        {
          "system": "NANDO",
          "code": "NANDO:2200424",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C3444",
          "display": null
        },
        {
          "system": "NORD",
          "code": "NORD:1840",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "OMIM:608710",
          "display": null
        },
        {
          "system": "Orphanet",
          "code": "Orphanet:900",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:195353004",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C3495801",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:1020056159",
          "display": null
        }
      ],
      "context": "Background Granulomatosis with polyangiitis (GPA) is a rare form of antineutrophil cytoplasmic antibody (ANCA)- associated vasculitis that can involve multiple organ systems, including the gastrointestinal (Gl) tract. Although Gl manifestations are relatively uncommon, they may be associated with serious complications and adverse outcomes. This s",
      "page": 1,
      "mention_count": 3,
      "pages_mentioned": [
        1,
        3,
        10
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": null,
      "enrichment_source": null
    },
    {
      "matched_text": "CSS",
      "preferred_label": "CSS",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": "ICD10CM:M30.1",
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0015943",
        "orpha": "Orphanet:183",
        "umls": "UMLS:C0008728",
        "mesh": "MESH:D015267"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0015943",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:3049",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:0007208",
          "display": null
        },
        {
          "system": "GARD",
          "code": "GARD:6111",
          "display": null
        },
        {
          "system": "ICD-10-CM",
          "code": "ICD10CM:M30.1",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:3088",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D015267",
          "display": null
        },
        {
          "system": "MedDRA",
          "code": "MedDRA:10048594",
          "display": null
        },
        {
          "system": "NANDO",
          "code": "NANDO:2200427",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C34481",
          "display": null
        },
        {
          "system": "NORD",
          "code": "NORD:973",
          "display": null
        },
        {
          "system": "Orphanet",
          "code": "Orphanet:183",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:82275008",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0008728",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:835880885",
          "display": null
        }
      ],
      "context": "is not a novel finding; it has been a cornerstone of risk stratification for decades, most notably through its inclusion in the Five-Factor Score (FFS). Initially developed for polyarteritis nodosa (PAN), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA, then CSS), the FFS was revised and validated by the French Vasculi-tis Study Group (FVSG) in 2009 to include GPA. In this large cohort of 1,108 patients, the revised FFS identified four factors including age >65 years, cardiac involvement, renal insufficiency (creatinine > 150 mol/L), and GI involvement tha",
      "page": 8,
      "mention_count": 2,
      "pages_mentioned": [
        8,
        9
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": null,
      "enrichment_source": null
    },
    {
      "matched_text": "Lam",
      "preferred_label": "LAM",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": "ICD10CM:J84.81",
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0011705",
        "orpha": null,
        "umls": "UMLS:C0751674",
        "mesh": "MESH:D018192"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0011705",
          "display": null
        },
        {
          "system": "ICD-10-CM",
          "code": "ICD10CM:J84.81",
          "display": null
        },
        {
          "system": "ICDO",
          "code": "ICDO:9174/1",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:148366",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D018192",
          "display": null
        },
        {
          "system": "NANDO",
          "code": "NANDO:1200430",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C3725",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "OMIM:606690",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0751674",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:902628446",
          "display": null
        }
      ],
      "context": "8. Rolak S, Pham MM, Lam-Himlin DM, Batheja MJ. New diagnosis of granulomatosis with polyangiitis presenting with oral Ulcerations, lleitis, and hematochezia. ACG Case Rep J. 2025;12(6):e01746.",
      "page": 10,
      "mention_count": 1,
      "pages_mentioned": [
        10
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Lameness Animal",
      "enrichment_source": "pubtator3"
    }
  ]
}